Pharmacophore-based virtual screening: a review of recent applications

被引:69
作者
Kim, Kyun-Hwan [2 ,3 ]
Kim, Nam Doo [4 ]
Seong, Baik-Lin [1 ]
机构
[1] Yonsei Univ, Dept Biotechnol, Translat Res Ctr Prot Funct Control, Coll Life Sci & Biotechnol, Seoul 120749, South Korea
[2] Konkuk Univ, Ctr Canc Res & Diagnost Med, Sch Med, Dept Pharmacol,IBST, Seoul 143701, South Korea
[3] Konkuk Univ, Inst Funct Genom, Seoul 143701, South Korea
[4] Equispharm Inc, R&D Ctr, Suwon Shi 443766, Gyeonggi Do, South Korea
关键词
anticancer; antivirus; drug discovery; pharmacophore; virtual screening; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DEPENDENT RNA-POLYMERASE; KINASE INHIBITORS; HIV-1; INTEGRASE; DRUG DISCOVERY; FATTY-ACIDS; IN-SILICO; IDENTIFICATION; MODEL; PROTEIN;
D O I
10.1517/17460441003592072
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Importance of the field: In research relating to the development of new drugs, hit identification and validations are critical for successful optimization of candidates. To achieve rapid identification of new lead compounds, high-throughput screening assays have been employed in many pharmaceutical companies and laboratories. However, their success depends on the assay system relevant to in vivo conditions and they are physically limited by the repertoire of compounds. As an alternative or complementary approach to high-throughput screening assays, virtual screening is an efficient method to identify drug candidates in silico from large chemical compound databases. its usefulness has been verified by current applications that successfully retrieved hit and lead identifications against various disease targets. However, for better application, the scoring functions for distinguishing possible active and inactive compounds must be improved. Areas covered in this review: In this review, we provide an overview of pharmacophore-based virtual screening methods with a special focus on their successful application towards finding hits against various disease targets. What the reader will gain: Readers will rapidly gain insight into the recent successful applications of pharmacophore-based virtual screening. They will acknowledge that this technique is a powerful and cost-effective alternative to high-throughput assays. Take home message: Although there are many hurdles yet to be resolved, virtual screening techniques will emerge as essential infrastructure and as a prerequisite for developing new lead compounds with therapeutic applications.
引用
收藏
页码:205 / 222
页数:18
相关论文
共 91 条
[11]   Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Anticancer Activity [J].
Chiang, Yi-Kun ;
Kuo, Ching-Chuan ;
Wu, Yu-Shan ;
Chen, Chung-Tong ;
Coumar, Mohane Selvaraj ;
Wu, Jian-Sung ;
Hsieh, Hsing-Pang ;
Chang, Chi-Yen ;
Jseng, Huan-Yi ;
Wu, Ming-Hsine ;
Leou, Jiun-Shyang ;
Song, Jen-Shin ;
Chang, Jang-Yang ;
Lyu, Ping-Chiang ;
Chao, Yu-Sheng ;
Wu, Su-Ying .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) :4221-4233
[12]  
CLEMENT OO, 2000, PHARMACOPHORE PERCEP, P71
[13]   Docking Ligands into flexible and solvated macromolecules. 2. Development and application of FITTED 1.5 to the virtual screening of potential HCV polymerase inhibitors [J].
Corbeil, Christopher R. ;
Englebienne, Pablo ;
Yannopoulos, Constantin G. ;
Chan, Laval ;
Das, Sanjoy K. ;
Bilimoria, Darius ;
L'Heureux, Lucille ;
Moitessier, Nicolas .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (04) :902-909
[14]  
CORINA, CORINA
[15]   Quinolone 3-carboxylic acid pharmacophore: Design of second generation HIV-1 integrase inhibitors [J].
Dayam, Raveendra ;
Al-Mawsawi, Laith Q. ;
Zawahir, Zahrah ;
Witvrouw, Myriam ;
Debyser, Zeger ;
Neamati, Nouri .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) :1136-1144
[16]   Pharmacophore-Based Discovery of Small-Molecule Inhibitors of Protein-Protein Interactions between HIV-1 Integrase and Cellular Cofactor LEDGF/p75 [J].
De Luca, Laura ;
Barreca, Maria Letizia ;
Ferro, Stefania ;
Christ, Frauke ;
Iraci, Nunzio ;
Gitto, Rosaria ;
Monforte, Anna Maria ;
Debyser, Zeger ;
Chimirri, Alba .
CHEMMEDCHEM, 2009, 4 (08) :1311-1316
[17]   Pharmacophore modelling and virtual screening for identification of new aurora-a kinase inhibitors [J].
Deng, Xiao-Qiang ;
Wang, Hui-Yuan ;
Zhao, Ying-Lan ;
Xiang, Ming-Li ;
Jiang, Pei-Du ;
Cao, Zhi-Xing ;
Zheng, Yu-Zhu ;
Luo, Shi-Dong ;
Yu, Luo-Ting ;
Wei, Yu-Quan ;
Yang, Sheng-Yong .
CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (06) :533-539
[18]   Predicting molecular interactions in silico:: I.: A guide to pharmacophore identification and its applications to drug design [J].
Dror, O ;
Shulman-Peleg, A ;
Nussinov, R ;
Wolfson, HJ .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (01) :71-90
[19]   Novel Approach for Efficient Pharmacophore-Based Virtual Screening: Method and Applications [J].
Dror, Oranit ;
Schneidman-Duhovny, Dina ;
Inbar, Yuval ;
Nussinov, Ruth ;
Wolfson, Haim J. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (10) :2333-2343
[20]   CHALCONES - A NEW CLASS OF ANTIMITOTIC AGENTS [J].
EDWARDS, ML ;
STEMERICK, DM ;
SUNKARA, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1948-1954